BioTech 365

MARCH 2, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Common bacteria modified to make designer sugar-based drug.Envisioning an animal-free drug supply, scientists have—for the first time—reprogrammed a common bacterium to make a designer polysaccharide molecule used … Continue (..)

Bacteria 40

Bacteria Bacterium Drugs Scientist 40

pharmaphorum

JULY 2, 2021

Swiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million upfront for North American co-marketing rights to its lead drug for Clostridium difficile infections. diff drug appeared first on. billion, but only included markets outside North America.

Bacterium 69

Bacterium Drugs Bacteria FDA Approval 69

Scienmag

OCTOBER 7, 2020

Study will influence the global elimination strategy for yaws Genome sequencing has shed light on the re-emergence of the bacterium that causes yaws, a neglected tropical disease of the skin, bones and joints. The re-emergence followed a mass drug administration (MDA) campaign that aimed to eliminate the disease in Papua New Guinea.

Genome 40

Genome Genomics Bacterium Drugs 40

Drug Discovery World

JANUARY 29, 2024

How phages work still a mystery In 2019, the team isolated a new, previously unknown virus that infects Pseudomonas aeruginosa, a bacterium that can cause serious respiratory diseases like pneumonia. However, you need to know exactly how a phage attacks a bacterium before you can select the right phages for a particular treatment.

Bacteria 52

Bacteria Scientist Bacterium Gene 52

Drug Discovery World

AUGUST 23, 2023

Using the device, called iCHip, the researchers discovered Clovibactin in a bacterium isolated from a sandy soil from North Carolina: E. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World The post Powerful new antibiotic isolated from microbial ‘dark matter’ appeared first on Drug Discovery World (DDW).

Bacteria 52

Bacteria Bacterium Development Research 52

Drug Discovery World

APRIL 18, 2024

Trial details The BCG vaccine was used in this trial because it is a live attenuated strain of Mycobacterium bovis – which is related to Mycobacterium tuberculosis , the bacterium which causes tuberculosis in humans – and BCG is known to be safe in humans.

Vaccination 52

Vaccination Vaccine Development Bacterium 52

XTalks

JUNE 14, 2022

The US Food and Drug Administration (FDA) found the 0.3 Previous and emerging research on this bacterium has associated it with intrinsic multi-drug resistance and nosocomial infections (also referred to as hospital-acquired infections). California-based Green Pharmaceuticals Inc. The SnoreStop NasoSpray.

Contamination 52

Contamination Bacterium Bacteria Branding 52

pharmaphorum

DECEMBER 24, 2020

Amgen has decided that a drug for leprosy and tuberculosis it inherited as part of its acquisition of Celgene’s psoriasis blockbuster Otezla last year would fare better in the hands of a non-profit company, dedicated to bringing affordable medicines to poorer countries. million patients every year and causing over a million deaths.

Bacterium 52

Bacterium Licensing Licensing Development 52

pharmaphorum

DECEMBER 1, 2021

The French group said that ORI-001, a vaccine based on recombinant proteins from the Cutibacterium acnes (formerly Propionibacterium acnes ) bacterium that is often found in acne lesions, could be the first ever vaccine for the condition. C acnes is implicated in moderate to severe acne, which is difficult to treat.

Vaccination 105

Vaccination Vaccine Development Hormones 105

XTalks

SEPTEMBER 29, 2023

Discussion also revolved around STEA, a species of bacterium in the same family as E. Furthermore, the report listed an additional 35 potential risks, identified by EREN members representing a range of global food safety organizations including the World Health Organization (WHO) and the US Food and Drug Administration (FDA).

Bacterium 105

Bacterium Contamination Insulin Drugs 105

XTalks

NOVEMBER 9, 2023

In this episode of the Xtalks Food Podcast, Sydney talks about fried rice syndrome, which refers to food poisoning caused by a bacterium called Bacillus cereus. Also in this episode, Sydney talks about why the US Food and Drug Administration (FDA) is set to remove brominated vegetable oil from its list of approved food additives.

Bacterium 52

Bacterium Bacteria Drugs Research 52

Pharma in Brief

NOVEMBER 20, 2023

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. Natural health product vs. regulated drug In Winning Combination Inc.

Production 52

Production Cosmetics Regulation Branding 52

Drug Discovery World

NOVEMBER 22, 2022

The study was conducted on a patient that carried the bacterium Pseudomonas aeruginosa as part of their gut microbiome. The post How antibiotic resistant gut bacteria cause lung infections appeared first on Drug Discovery World (DDW). Leading cause of hospital infections.

Bacteria 98

Bacteria Bacterium Development Drugs 98

Roots Analysis

NOVEMBER 11, 2023

The Centers for Disease Control and Prevention (CDC) recently issued a formal health advisory in response to an unprecedented outbreak of carbapenem-resistant Pseudomonas aeruginosa (CRPA), a bacterium notorious for its resistance to specific antibiotics, thereby instigating severe infections in affected individuals.

Contamination 52

Contamination Bacterium Branding Bacteria 52

pharmaphorum

JUNE 16, 2022

Sweden’s Hansa Biopharma has claimed a positive opinion from NICE for Idefirix, which becomes the first drug cleared for NHS use in a group of kidney transplant patients for whom finding a donor is particularly challenging. “People who are highly sensitised to HLAs can often be waiting a long time for a kidney transplant.

Antibody 52

Antibody Bacterium Clinical Trials Clinical Trials 52

XTalks

JULY 28, 2021

Merck has scored US Food and Drug Administration (FDA) approval for its next-generation pneumonia vaccine Vaxneuvance that covers 15 different strains of the pneumococcal bacteria that causes the infection. Compared to Vaxneuvance’s targeting of 15 different strains of the bacterium, Pfizer’s shot protects against 20.

FDA Approval 89

FDA Approval Vaccination Vaccine Immune Response 89

XTalks

JULY 25, 2023

Emergent BioSolutions, a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, has achieved a significant milestone with the approval of its Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) vaccine by the US Food and Drug Administration (FDA). Anthrax is a rare, yet severe disease caused by the bacterium B.

FDA Approval 98

FDA Approval Vaccination Vaccine Antibody 98

Drug Discovery World

NOVEMBER 17, 2022

Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery. . The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape.

Bacteria 52

Bacteria Engineer Gene Genetics 52

Pfizer

JANUARY 27, 2023

Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. An estimated 1.9 million people suffer visual impairment because of infection, and women are up to four times more likely to be blinded by trachoma than men. iii Zithromax is not approved in the United States or European Union to treat trachoma.

Bacteria 75

Bacteria Medicine Containment Manufacturing 75

pharmaphorum

OCTOBER 19, 2022

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data. The post Synlogic preps phenylketonuria drug for phase 3 after mid-stage win appeared first on.

Drugs 98

Drugs Bacterium Genetic Disease Sales 98

XTalks

AUGUST 2, 2023

Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. billion the drug generated in 2021. billion in 2022. billion, a 26.55

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 24, 2020

From rare disease drug approvals to treatments involving immunotherapies and gene therapies and awarding of a Nobel Prize to the inventors of the gene-editing tool CRISPR, 2020 was a year of great activity and productivity despite the backdrop of the pandemic. Drugs, Testing and Vaccines. Drug Approvals.

Life Science 111

Life Science Vaccination Vaccine Gene 111

pharmaphorum

OCTOBER 5, 2022

Some gonorrhoea infections have become untreatable with all seven main antibiotic classes – a situation last encountered in the 1920s before the advent of effective drugs for the bacterium. At the moment most cases are treated with azithromycin, with intravenous ceftriaxone generally reserved as a last-line therapy.

Vaccination 98

Vaccination Vaccine Immune Response Bacterium 98

The Pharma Data

MAY 13, 2021

It is this bacterium that. Using drugs or over the counter. or drugs will cause constipation. The answer is: It Could Cost You Doctor Visits, Drugs, Time from Work, Surgery, or Hospital bills!!! You will want to know about these new discoveries. The Colon Diseases You Develop When. You Have Constipation.

Doctors 52

Doctors Doctor Bacteria Production 52

Drug Discovery World

OCTOBER 4, 2022

They relied on a theory called colonisation resistance, which explains that any bacterium, when introduced into an existing colony, will only survive if it can fill a niche not already occupied. The post Stanford researchers construct the most complete synthetic microbiome appeared first on Drug Discovery World (DDW).

Research 52

Research Bacteria Scientist Bacterium 52

The Pharma Data

JUNE 2, 2022

In July 2021, the US Food and Drug Administration granted Breakthrough Therapy designation for AFX3772 to prevent S. The bacterium Streptococcus pneumoniae causes pneumococcal disease. pneumoniae invasive disease and pneumonia in adults 50 years and above. Phase III is expected to start in the short term. About Pneumococcal disease.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

MAY 31, 2022

In July 2021, the US Food and Drug Administration granted Breakthrough Therapy designation for AFX3772 to prevent S. The bacterium Streptococcus pneumoniae causes pneumococcal disease. pneumoniae invasive disease and pneumonia in adults 50 years and above. Phase III is expected to start in the short term. Pneumococcal disease.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

NOVEMBER 26, 2020

Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.?

Containment 52

Containment Bacterium Development Sales 52

The Pharma Data

FEBRUARY 21, 2022

Trachoma is a devastating eye disease caused by infection with the bacterium Chlamydia trachomatis. The disease. The infection spreads from person to person through contaminated fingers, fomites and flies that have come into contact with discharge from the eyes or nose of an infected person.

Bacterium 52

Bacterium Contamination Manufacturing Drugs 52